Salona Global Medical Device Corporation
Symbol: SGMD.V
TSX
0.22
CADMarket price today
-15.8062
P/E Ratio
0.2483
PEG Ratio
17.24M
MRK Cap
- 0.00%
DIV Yield
Salona Global Medical Device Corporation (SGMD-V) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 8.1 | 7.6 | 9.2 | |||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0.5 | 0.8 | |||||||||
balance-sheet.row.net-receivables | 0 | 7 | 0.1 | 0.1 | |||||||||
balance-sheet.row.inventory | 0 | 5 | 0 | 0 | |||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-current-assets | 0 | 20 | 13.1 | 9.3 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 5.4 | 0 | 0 | |||||||||
balance-sheet.row.goodwill | 0 | 9.8 | 0 | 0 | |||||||||
balance-sheet.row.intangible-assets | 0 | 6.9 | 0 | 0 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 16.8 | 0 | 0 | |||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.5 | 0 | 0 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 22.6 | 0 | 0 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 42.7 | 13.1 | 9.3 | |||||||||
balance-sheet.row.account-payables | 0 | 2.9 | 0.5 | 0.4 | |||||||||
balance-sheet.row.short-term-debt | 0 | 5.9 | 0 | 0 | |||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 4.6 | 0 | 0 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 13.6 | 6 | 0 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6.4 | 0 | 0 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 4.2 | 0 | 0 | |||||||||
balance-sheet.row.total-liab | 0 | 29.5 | 6.5 | 0.4 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 38.5 | 31.1 | 31.1 | |||||||||
balance-sheet.row.retained-earnings | 0 | -33.4 | -29 | -26.9 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1 | 0.9 | 1.4 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 7 | 3.6 | 3.4 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 13.2 | 6.6 | 9 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 42.7 | 13.1 | 9.3 | |||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | 13.2 | 6.6 | 9 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 0 | 0.5 | 0.8 | |||||||||
balance-sheet.row.total-debt | 0 | 10.5 | 0 | 0 | |||||||||
balance-sheet.row.net-debt | 0 | 2.5 | -7.1 | -8.3 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -4.4 | -2.7 | -1.8 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0.8 | 0.8 | 0.1 | ||||||||
cash-flows.row.deferred-income-tax | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 1.2 | 0.2 | 0 | ||||||||
cash-flows.row.change-in-working-capital | 0 | -0.2 | 1.3 | 1.3 | ||||||||
cash-flows.row.account-receivables | 0 | -2.1 | -2.1 | 0 | ||||||||
cash-flows.row.inventory | 0 | 0.2 | 0.2 | 0 | ||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-working-capital | 0 | 1.6 | 3.1 | 0 | ||||||||
cash-flows.row.other-non-cash-items | 0 | -1.1 | -0.5 | 0.3 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.acquisitions-net | 0 | -5.1 | -5.1 | 0 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -0.4 | -0.9 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.5 | 0.4 | 0 | ||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 5.1 | 0 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -4.6 | 0.1 | -0.9 | ||||||||
cash-flows.row.debt-repayment | 0 | -2.5 | -2.5 | 0 | ||||||||
cash-flows.row.common-stock-issued | 0 | 4.3 | 4.3 | 0 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-financing-activites | 0 | 2.2 | 3.7 | 0 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3.9 | 5.4 | 0 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -0.1 | -0.4 | 0.1 | ||||||||
cash-flows.row.net-change-in-cash | 0 | -4.4 | 4.2 | -1 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 8.1 | 12.5 | 8.3 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 12.5 | 8.3 | 9.3 | ||||||||
cash-flows.row.operating-cash-flow | 0 | -3.7 | -1 | -0.1 | ||||||||
cash-flows.row.capital-expenditure | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.free-cash-flow | 0 | -3.8 | -1 | -0.1 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 18.3 | 0 | 0.4 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 12.4 | 12.4 | 0.4 | ||||||||
income-statement-row.row.gross-profit | 0 | 6 | -12.4 | 0 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | -3.8 | -1.6 | 0 | ||||||||
income-statement-row.row.operating-expenses | 0 | 6.6 | 1 | 1.7 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 18.9 | 1 | 2.1 | ||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.4 | 0 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -3.5 | -1.6 | 0 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | -3.8 | -1.6 | 0 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -3.5 | -1.6 | 0 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.4 | 0 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0.8 | 0.8 | 0.1 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | -4.5 | -1 | -1.7 | ||||||||
income-statement-row.row.income-before-tax | 0 | -4.5 | -2.7 | -1.8 | ||||||||
income-statement-row.row.income-tax-expense | 0 | -0.1 | -0.1 | 0.6 | ||||||||
income-statement-row.row.net-income | 0 | -4.4 | -2.7 | -2.3 |
Frequently Asked Question
What is Salona Global Medical Device Corporation (SGMD.V) total assets?
Salona Global Medical Device Corporation (SGMD.V) total assets is 42681612.000.
What is enterprise annual revenue?
The annual revenue is N/A.
What is firm profit margin?
Firm profit margin is 0.357.
What is company free cash flow?
The free cash flow is -0.015.
What is enterprise net profit margin?
The net profit margin is -0.023.
What is firm total revenue?
The total revenue is -0.080.
What is Salona Global Medical Device Corporation (SGMD.V) net profit (net income)?
The net profit (net income) is -4372019.000.
What is firm total debt?
The total debt is 10533056.000.
What is operating expences number?
The operating expences are 6570013.000.
What is company cash figure?
Enretprise cash is 0.000.